Prior studies have shown that targeting key points in the Hedgehog pathway, such as SHh, SMO, and GLI, can suppress lung cancer cell proliferation, enhance lung cancer cell apoptosis, and enhance drug sensitivity in drug-resistant lung cancer cells. This evidence concerns the gene GLI1 and lung carcinoma.